Lindbrook Capital, LLC - ALDEYRA THERAPEUTICS INC ownership

ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 119 filers reported holding ALDEYRA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 1.46 and the average weighting 0.3%.

Quarter-by-quarter ownership
Lindbrook Capital, LLC ownership history of ALDEYRA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$5,197
-20.4%
7780.0%0.00%0.0%
Q2 2023$6,527
+82.1%
778
+115.5%
0.00%
Q1 2023$3,585
+0.6%
361
-29.5%
0.00%
Q4 2022$3,564
-10.9%
512
-32.7%
0.00%
-100.0%
Q3 2022$4,000
+33.3%
7610.0%0.00%
Q2 2022$3,0000.0%7610.0%0.00%
Q1 2022$3,000
-70.0%
761
-70.1%
0.00%
-100.0%
Q4 2021$10,000
-37.5%
2,541
-15.3%
0.00%
-66.7%
Q3 2019$16,000
-11.1%
3,0000.0%0.01%
-14.3%
Q2 2019$18,0003,0000.01%
Other shareholders
ALDEYRA THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 3,015,668$25,301,45430.67%
Perceptive Advisors 11,350,085$95,227,2132.76%
JOHNSON & JOHNSON 394,834$3,312,6571.03%
Affinity Asset Advisors, LLC 150,000$1,258,5000.44%
Prosight Management, LP 299,022$2,508,7940.38%
Tri Locum Partners LP 73,067$613,0320.23%
WOODSTOCK CORP 137,179$1,150,9320.14%
Joseph P. Lucia & Associates, LLC 22,781$191,1330.13%
Palo Alto Investors LP 160,800$1,349,1120.11%
Verition Fund Management LLC 930,074$7,803,3210.10%
View complete list of ALDEYRA THERAPEUTICS INC shareholders